|

Alpelisib 300 mg Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Piqray

Pipeline

Phase 1: 1

Top Sponsors

  • Columbia University1

Indications

  • Liver Disease1
  • Prediabetic State1
  • Non Alcoholic Fatty Liver Disease1
  • Diabetes1
  • Insulin Resistance1

New York, New York1 trial

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Columbia University Irving Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.